Deborah Keller

CEO
Pharmaceutical
Covance
United States of America

Biography

Deborah was CEO of Covance, the world’s most comprehensive drug development company. She lead an organization of more than 12,000 employees in 60 countries around the globe involved in all phases of drug development, from discovery throughout the product lifecycle. Covance has helped pharmaceutical and biotech companies develop one-third of all prescription drugs in the marketplace today. Covance is the drug development business of Laboratory Corporation of America® Holdings (LabCorp®) and Deborah is a member of the LabCorp Executive Committee.

Research Interest

Pharmaceutical

Global Experts from United States of America

Global Experts in Subject

Share This Profile

Recent Expert Updates

Matthew L Stone
pediatrics
University of Virginia Health System; Charlottesville, VA
United States of America
Dr. Matthew
pediatrics
University of Virginia Health System; Charlottesville, VA
United States of America
Dr. L Stone Matthew
pediatrics
University of Virginia Health System; Charlottesville, VA
United States of America
Dr. L Stone
pediatrics
University of Virginia Health System; Charlottesville, VA
United States of America
Dr. Matthew L Stone
pediatrics
University of Virginia Health System; Charlottesville, VA
United States of America
Dr. R Sameh
pediatrics
King Abdul Aziz University
United Arab Emirates
Dr. R Ismail,
pediatrics
King Abdul Aziz University
United Arab Emirates
Sameh R Ismail,
pediatrics
King Abdul Aziz University
United Arab Emirates
Dr. Sameh R Ismail,
pediatrics
King Abdul Aziz University
United Arab Emirates
Dr. William
pediatrics
Maimonides Medical Center
United States of America